Jupiter Topco LLC Purchases New Position in Heartflow, Inc. $HTFL

Jupiter Topco LLC acquired a new position in Heartflow, Inc. (NASDAQ:HTFL) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 2,419,336 shares of the company’s stock, valued at approximately $70,983,000. Jupiter Topco LLC owned approximately 2.81% of Heartflow at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new stake in Heartflow during the fourth quarter valued at $27,000. Russell Investments Group Ltd. acquired a new position in shares of Heartflow in the fourth quarter worth about $45,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the third quarter worth about $59,000. Essential Partners LLC purchased a new stake in shares of Heartflow during the 1st quarter worth about $57,000. Finally, Strs Ohio purchased a new position in shares of Heartflow in the 4th quarter valued at about $99,000.

Insider Buying and Selling

In other Heartflow news, insider Campbell Rogers sold 9,219 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $41.23, for a total value of $380,099.37. Following the completion of the sale, the insider directly owned 86,459 shares of the company’s stock, valued at $3,564,704.57. This trade represents a 9.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John C.M. Farquhar sold 38,900 shares of Heartflow stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the transaction, the chief executive officer owned 457,935 shares in the company, valued at approximately $16,027,725. This represents a 7.83% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 191,271 shares of company stock worth $7,089,136. 7.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

HTFL has been the topic of several research analyst reports. Wells Fargo & Company raised their price objective on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Stifel Nicolaus increased their target price on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Finally, William Blair initiated coverage on shares of Heartflow in a research report on Monday, May 4th. They issued an “outperform” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Heartflow presently has an average rating of “Moderate Buy” and a consensus price target of $43.43.

Heartflow Trading Down 1.7%

HTFL opened at $48.10 on Friday. The firm has a market capitalization of $4.18 billion and a PE ratio of -26.28. Heartflow, Inc. has a twelve month low of $20.13 and a twelve month high of $51.19. The firm’s 50-day moving average price is $31.97 and its 200 day moving average price is $28.93.

Heartflow (NASDAQ:HTFL) last released its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million for the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. Heartflow’s revenue for the quarter was up 47.7% on a year-over-year basis. As a group, analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.